<DOC>
	<DOCNO>NCT00999739</DOCNO>
	<brief_summary>Randomised study compare two pneumococcal vaccination strategy HIV-infected adult moderate immunossupression ( CD4 200 500 cells/uL viral load 5logs ) , one conjugate heptavalent vaccine ( Prevenar , Wyeth-Lederle ) follow polysaccharide vaccine 4 week ( Aventis-Pasteur ) , two one dose polysaccharide vaccine . Determination secondary effect relate vaccine determination antibody concentration ( ELISA ) avidity ( ELISA thiocyanate ) opsonophagocytosis kill activity seven serotypes include heptavalent vaccine vaccination , 4 week , 8 week , at48 week 96 week . A sample 220 HIV-infected adult ( 110 group ) need detect difference 10 % type I error 5 % limited population 2500 HIV-infected adult . The main hypothesis : immunogenicity pneumococcal vaccination conjugate polysaccharide vaccine superior immunogenicity induce polysaccharide vaccination alone ( antibody concentration ) , avidity opsonophagocytosis induce two vaccine well one polysaccharide vaccine alone , vaccination safe .</brief_summary>
	<brief_title>Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults</brief_title>
	<detailed_description>Randomised study compare two pneumococcal vaccination strategy HIV-infected adult moderate immunossupression ( CD4 200 500 cells/uL viral load 5logs ) , one conjugate heptavalent vaccine ( Prevenar , Wyeth-Lederle ) follow polysaccharide vaccine 4 week ( Aventis-Pasteur ) , two one dose polysaccharide vaccine . A sample 220 HIV-infected adult randomise receive twe strategy one ( 110 patient ) one dose heptavalent conjugate vaccine day 0 one dose polysaccharide vaccine week 4 ( deltoid muscle ) ; strategy two ( 110 patient ) one dose polysaccharide vaccine day 0 . Secondary effect vaccine evaluate phone interview 3 day vaccination . Blood sample take day 0 ( first vaccine ) , week 4 polysaccharide group one , 4 week polysaccharide group two ) week 8 group one , week 48 96 group Antibody concentration , avidity , opsonophagocytic killing activity measure sample serotypes 4,14,19F,23F,6B,18C,9V . Antibody concentration , avidity , opsonophagocytic killing activity compare vaccine group , prevaccination 4,8 , 48 96 week vaccination . Risk factor associate good antibody response ( antibody duplication antibody duplication plus achieve level 1ug/ml ) measure 8 , 48 and96 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>HIVinfected adult CD4 200 500 cels/ul viral load 5 logarithm previous pneumococcal vaccine , pregnancy , advance renal liver disease , vaccine antibiotic 6 week , immunosuppression , immunoglobulins investigation drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>pneumococcal vaccine</keyword>
	<keyword>HIV</keyword>
	<keyword>antibody response</keyword>
	<keyword>antibody affinity</keyword>
	<keyword>Antibody formation</keyword>
	<keyword>Phagocytosis</keyword>
</DOC>